KT-2962

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameKT-2962
Drug Alias NameKT-2962KT2-962
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThromboxane A2 receptor antagonistsFree radicals scavengers
TargetsThromboxane A2 receptorFree radicals
Therapy Area/IndicationsMigraine DisordersAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKotobuki
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKotobuki
Active IndicationsN/A
Inactive IndicationsMigraine DisordersAsthma

Other Information

ATC CodeN/A
Related LinksN/A